Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B by Women With Climacteric Syndrome
Climacteric Syndrome, Menopause

About this trial
This is an interventional treatment trial for Climacteric Syndrome focused on measuring Succinate, B complex vitamins, menopause
Eligibility Criteria
Inclusion Criteria:
- Female patients, 42-60 years of age;
- Patient with diagnosis of "climacteric syndrome", in typical or non-complicated form, mild or moderate vegetative symptoms during menopause i.e. absence of menstrual period for at least 1 year;
- Ability to read and understand informed consent form for the study's participation;
- Patients without risk factors and changes in the breast tissue based on the mammogram;
- Patients with medical history of risk factors without changes in the breast tissue;
- Ability to adhere to the conditions of the study.
Exclusion Criteria:
- Presence of female reproductive system cancers (breast cancer, cervical cancer etc.);
- Presence of extragenital oncological conditions, except those in complete remission for 5 years or more;
- Conditions requiring emergency or planned hospitalization in the next 6 months;
- Presence of hormonally-active extragenital endocrine diseases (thyroid, adrenal, pituitary, hypothalamus);
- Surgical interventions done on sex organs or breasts, 1 year or less prior to the screening;
- Any surgeries done less than 3 months prior to the screening;
- Patients receiving HRT;
- Psychiatric conditions;
- Diabetes;
- Total ovariectomy
Patients taking any other dietary supplements that can affect climacteric syndrome within the last month before enrolling in the study
- High risk of non-compliance
Sites / Locations
- Sechenov First Moscow Medical University
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Amberen and Smart B
Placebo
Amberen - a dietary supplement: 2 capsules (one while capsule 200 mg and one orange capsule 200 mg) are taken once a day with a meal, preferably after breakfast, for 3 months. SMART В - a dietary supplement: 1 capsule per day (166 mg) is taken once a day with a meal, preferably after breakfast, for 3 months, concurrently with Amberen.
Placebo is taken as follows: 3 capsules (one while capsule 200 mg, one orange capsule 200 mg, one capsule 166mg) are taken once a day with a meal, preferably after breakfast, for 3 months.